Eldad Ben Shitrit Israel
Seniority 33 years , Professor, Head of the division of rheumatology and clinical treatment of Familial Mediterranean Fever ☺ reviews $ Prices for treatments and diagnostics
✆ Make an appointment:
+74954812786​
Our company is the official representative of the doctor Eldad Ben Shitrit worldwide
Get consultation

Eldad Ben Shitrit

Professor, Head of the division of rheumatology and clinical treatment of Familial Mediterranean Fever
65 years / Seniority 33 years
Get consultation
Our company is the official representative of the doctor Eldad Ben Shitrit worldwide
Specialization
Price for personal appointment $600
Make an appointment

Professor Ben Sheetrit opened a new antigen KD52 and contribute to the treatment of autoimmune diseases has been awarded a number of international awards.


Treat diseases

Professor Ben Sheetrit belongs to the discovery of a new antigen KD52, which, along with other antinuclear antibodies, has important diagnostic value for detection of systemic autoimmune diseases. For his contribution to the study of autoimmune diseases has been awarded a number of international awards.

Professor Ben Sheetrit is a member of numerous medical societies and organizations. He wrote more than two hundred scientific articles and publications.

He has extensive experience in the field of rheumatology and clinical immunology. Today, Professor Ben Sheetrit in charge of a division of rheumatology clinic and treatment of familial Mediterranean fever

He speaks:. Hebrew, Arabic and English

A graduate of the Faculty of Medicine of the Hebrew University in Jerusalem.. Residency held at the medical center "Hadassah" in the field of rheumatology. For training internship in a research center named Scripps Clinic (San Diego, USA), where he specialized.

Price for diagnostic and manipulations
from 450$
Second Opinion (Second medical opinion)
Price request
from 200$
Skype consultation
Price request
Give feedback
Question and answers

No questions asked

Ask a question

By continuing to use this site, you agree to our Terms of Use cookie-files.

Accept